Literature DB >> 29748861

Response to the letter to the editor by Dr. Yasar and Babaoglu on the recent publication of Kokki et al. on the pharmacokinetics of metoprolol bioavailability in coronary artery bypass surgery patients.

Hannu Kokki1, Jari Halonen2,3, Juha Hartikainen2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29748861     DOI： 10.1007/s00228-018-2476-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery.

Authors:  Jari Halonen; Tapio Hakala; Tommi Auvinen; Jari Karjalainen; Anu Turpeinen; Ari Uusaro; Pirjo Halonen; Juha Hartikainen; Mikko Hippeläinen
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

2.  How do different extracorporeal circulation systems affect metoprolol bioavailability in coronary artery bypass surgery patients.

Authors:  Hannu Kokki; Martin Maaroos; Sten Ellam; Jari Halonen; Ilkka Ojanperä; Merja Ranta; Veli-Pekka Ranta; Aleksandra Tolonen; Oscar Lindberg; Matias Viitala; Juha Hartikainen
Journal:  Eur J Clin Pharmacol       Date:  2018-03-09       Impact factor: 2.953

3.  Does coronary artery bypass surgery affect metoprolol bioavailability.

Authors:  Antti Valtola; Hannu Kokki; Merja Gergov; Ilkka Ojanperä; Veli-Pekka Ranta; Tapio Hakala
Journal:  Eur J Clin Pharmacol       Date:  2007-02-28       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.